A breakthrough study by Irish researchers pinpointed a biomarker for the early identification of the potentially deadly condition in “high-risk” patient groups
A breakthrough study by Irish researchers pinpointed a biomarker for the early identification of the potentially deadly condition in “high-risk” patient groups